Search Results - "Jackson, Christopher M"

Refine Results
  1. 1

    Mechanisms of immunotherapy resistance: lessons from glioblastoma by Jackson, Christopher M., Choi, John, Lim, Michael

    Published in Nature immunology (01-09-2019)
    “…Glioblastoma (GBM) is the deadliest form of brain cancer, with a median survival of less than 2 years despite surgical resection, radiation, and chemotherapy…”
    Get full text
    Journal Article
  2. 2

    Supercharged chimeric antigen receptor T cells in solid tumors by Pant, Ayush, Jackson, Christopher M

    Published in The Journal of clinical investigation (15-08-2022)
    “…Chimeric antigen receptor (CAR) T cells have demonstrated success in treating select hematological malignancies, but their activity in solid tumors has been…”
    Get full text
    Journal Article
  3. 3

    Dominant party politics and ethnic coordination after conflict: the Serb List in Kosovo by Jackson, Christopher M.

    Published in Democratization (18-08-2023)
    “…Since entering Kosovo politics in 2013, the Serb List (SL) monopolized political representation in the Kosovo Serb community. This study addresses dual…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma by Maxwell, Russell, Jackson, Christopher M., Lim, Michael

    Published in Current treatment options in oncology (01-08-2017)
    “…Opinion statement Immune checkpoint inhibitors have changed the landscape of cancer immunotherapy and are being integrated into the standard of care for a…”
    Get full text
    Journal Article
  6. 6

    Immunotherapy for Brain Cancer: Recent Progress and Future Promise by JACKSON, Christopher M, LIM, Michael, DRAKE, Charles G

    Published in Clinical cancer research (15-07-2014)
    “…Immunotherapy is emerging as the newest pillar of cancer treatment, with the potential to assume a place alongside surgical debulking, radiotherapy, and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo by Durham, Nicholas M, Nirschl, Christopher J, Jackson, Christopher M, Elias, Jimmy, Kochel, Christina M, Anders, Robert A, Drake, Charles G

    Published in PloS one (05-11-2014)
    “…Lymphocyte Activation Gene - 3 (LAG-3) is an immune checkpoint molecule that regulates both T-cell activation and homeostasis. However, the molecular…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The Translational Potential of Microglia and Monocyte-Derived Macrophages in Ischemic Stroke by Wicks, Elizabeth E., Ran, Kathleen R., Kim, Jennifer E., Xu, Risheng, Lee, Ryan P., Jackson, Christopher M.

    Published in Frontiers in immunology (20-06-2022)
    “…The immune response to ischemic stroke is an area of study that is at the forefront of stroke research and presents promising new avenues for treatment…”
    Get full text
    Journal Article
  11. 11

    Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma by Garzon-Muvdi, Tomas, Theodros, Debebe, Luksik, Andrew S, Maxwell, Russell, Kim, Eileen, Jackson, Christopher M, Belcaid, Zineb, Ganguly, Sudipto, Tyler, Betty, Brem, Henry, Pardoll, Drew M, Lim, Michael

    Published in Oncotarget (17-04-2018)
    “…The glioblastoma (GBM) immune microenvironment is highly suppressive as it targets and hinders multiple components of the immune system. Checkpoint blockade…”
    Get full text
    Journal Article
  12. 12

    Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review by Kannapadi, Nivedha V., Shah, Pavan P., Mathios, Dimitrios, Jackson, Christopher M.

    Published in Frontiers in oncology (31-05-2022)
    “…No portion of this manuscript has previously been presented. Meningiomas, the most common primary intracranial tumors, are histologically categorized by the…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Immunotherapy for Glioblastoma: Playing Chess, Not Checkers by Jackson, Christopher M, Lim, Michael

    Published in Clinical cancer research (01-09-2018)
    “…Patients with glioblastoma (GBM) exhibit a complex state of immune dysfunction involving multiple mechanisms of local, regional, and systemic immunosuppression…”
    Get full text
    Journal Article
  15. 15

    CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression by Luksik, Andrew S, Yazigi, Eli, Shah, Pavan, Jackson, Christopher M

    Published in Cancers (23-02-2023)
    “…Glioblastoma (GBM) is the most common primary brain tumor, yet prognosis remains dismal with current treatment. Immunotherapeutic strategies have had limited…”
    Get full text
    Journal Article
  16. 16

    Ethnic Protection Rackets: Turkish Cypriot Statebuilding before 1974 by Jackson, Christopher M.

    Published in Civil wars (02-10-2021)
    “…For the ten years prior to the Turkish partition of Cyprus into Greek and Turkish Cypriot zones, the Turkish Cypriot community lived in distinct ethnic…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Pediatric glioblastoma: mechanisms of immune evasion and potential therapeutic opportunities by Njonkou, Rosy, Jackson, Christopher M., Woodworth, Graeme F., Hersh, David S.

    Published in Cancer Immunology, Immunotherapy (01-08-2022)
    “…Pediatric glioblastoma is relatively rare compared with its adult counterpart but is associated with a similarly grim prognosis. Available data indicate that…”
    Get full text
    Journal Article
  19. 19

    Linking to the State: Hierarchical Statebuilding After Ethnic Conflict in the Western Balkans by Jackson, Christopher M.

    Published in Ethnopolitics (27-05-2021)
    “…Fighting in Kosovo, Serbia, and Macedonia ended with internationally-sponsored settlements aimed at constituting unified states, but participatory politics by…”
    Get full text
    Journal Article
  20. 20

    Therapeutic implications for the PD-1 axis in cerebrovascular injury by Feghali, James, Jackson, Christopher M.

    Published in Neurotherapeutics (04-10-2024)
    “…Since the discovery and characterization of the PD-1/PD-L pathway, mounting evidence has emerged regarding its role in regulating neuroinflammation following…”
    Get full text
    Journal Article